Lavaca Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Lavaca Capital's MRK Position: Q3 2026 in Review
Lavaca Capital increased its Merck (MRK) stake by 0.43% in Q3 2026, buying an estimated $39.2K and bringing the position to 66,057 shares worth $9.6M. The position accounts for 0.89% of the portfolio, ranked #10.
Lavaca Capital first reported a position in MRK in Q4 2018 and has held it in 32 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Lavaca Capital held 66,057 shares of Merck worth $9.6M as of Q3 2026.
- Lavaca Capital bought 284 Merck shares in Q3 2026, an estimated $39.2K.
- Merck made up 0.89% of Lavaca Capital's portfolio in Q3 2026, its #10 holding.
- Lavaca Capital first reported a position in Merck in Q4 2018 and has held it in 32 quarters since.
- 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Lavaca Capital's 13F filing for Q3 2026, filed 16 Nov 2026.